Table 3.
Summary of CpG sites from cannabis-only and cannabis with tobacco users vs. non-users.
| Cannabis-only | Tobacco + Cannabis | Both | |||
|---|---|---|---|---|---|
| Differentially methylated loci (FWER = 0.05) | 0 | 6 | |||
| Differentially methylated loci (P < 0.001) | |||||
| Total | 521 | 533 | |||
| Hypermethylated | 420 | 80.6% | 403 | 75.6% | 2 |
| Hypomethylated | 101 | 19.4% | 130 | 24.4% | 1 |
| Hyper (cannabis) Hypo (cannabis + tobacco) | 1 | ||||
| Location | |||||
| Intron | 216 | 41.5% | 264 | 49.5% | |
| Exon | 97 | 18.6% | 65 | 12.2% | |
| Exon Boundary | 0 | 0 | |||
| Promoter | 89 | 17.1% | 60 | 11.3% | |
| 3ʹ UTR | 3 | 0.6% | 1 | 0.2% | |
| 5ʹ UTR | 0 | 0 | |||
| 3ʹ (downstream) | 62 | 11.9% | 76 | 14.3% | |
| 5ʹ (upstream) | 54 | 10.4% | 67 | 12.6% |
Counts of significant sites at P = 0.001 and at a Benjamini and Hochberg adjusted P < 0.05. ‘Both’ indicates the number of CpG sites of each type that are present and shared across both analyses.
FWER family-wise error rate.